Dual role of cAMP in the transcriptional regulation of Multidrug Resistance-Associated Protein 4 (MRP4) in pancreatic adenocarcinoma cell lines

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Carozzo, Alejandro ^a,c   Diez, Federico ^a,c   Gomez, Natalia ^a,c   Cabrera, Maia ^a,c   Shayo, Carina ^a,b   Davio, Carlos ^a,c   Fernández, Natalia ^a,c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOHEXIMIDE; EPAC2 PROTEIN; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; RAP1 PROTEIN; UNCLASSIFIED DRUG; ABCC4 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

ADENOCARCINOMA CELL LINE; ARTICLE; CELL LEVEL; CONTROLLED STUDY; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; MRP4 GENE; PANCREATIC ADENOCARCINOMA CELL LINE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ADENOCARCINOMA; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; CYCLIC AMP; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84925635478     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120651     Document Type: Article

References (38)

1. Beavo JA, Brunton LL. Cyclic nucleotide research - still expanding after half a century. Nat Rev Mol Cell Biol. 2002; 3: 710-718. PMID: 12209131
2. Wielinga PR, van der Heijden I, Reid G, Beijnen JH, Wijnholds J, Borst P. Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem. 2003; 278: 17664-17671. PMID: 12637526
3. Chen ZS, Lee K, Kruh GD. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J Biol Chem. 2001; 276: 33747-33754. PMID: 11447229
4. van Aubel RA, Smeets PH, Peters JG, Bindels RJ, Russel FG. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol. 2002; 13: 595-603. PMID: 11856762
5. Reid G, Wielinga P, Zelcer N, van der Heijden I, Kuil A, de Haas M, et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal anti-inflammatory drugs. Proc Natl Acad Sci U S A. 2003; 100: 9244-9249. PMID: 12835412
6. Russel FG, Koenderink JB, Masereeuw R. Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci. 2008; 29: 200-207. doi: 10.1016/j.tips.2008.01.006 PMID: 18353444
7. Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology. 2003; 38: 374-384. PMID: 12883481
8. Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P, Du G, et al. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol. 2004; 24: 7612-7621. PMID: 15314169
9. Ritter CA, Jedlitschky G, Meyer zu Schwabedissen H, Grube M, Kock K, Kroemer HK. Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev. 2005; 37: 253-278. PMID: 15747503
10. Chen ZS, Lee K, Walther S, Raftogianis RB, Kuwano M, Zeng H, et al. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res. 2002; 62: 3144-3150. PMID: 12036927
11. Reid G, Wielinga P, Zelcer N, De Haas M, Van Deemter L, Wijnholds J, et al. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol Pharmacol. 2003; 63: 1094-1103. PMID: 12695538
12. Rius M, Hummel-Eisenbeiss J, Hofmann AF, Keppler D. Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. Am J Physiol Gastrointest Liver Physiol. 2006; 290: G640-649. PMID: 16282361
13. Zelcer N, Reid G, Wielinga P, Kuil A, van der Heijden I, Schuetz JD, et al. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem J. 2003; 371: 361-367. PMID: 12523936
14. Copsel S, Garcia C, Diez F, Vermeulem M, Baldi A, Bianciotti LG, et al. Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation. J Biol Chem. 2011; 286: 6979-6988. doi: 10.1074/jbc.M110.166868 PMID: 21205825
15. Sun Y, Shi N, Lu H, Zhang J, Ma Y, Qiao Y, et al. ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma. Carcinogenesis. 2014; 35: 1941-1950. doi: 10.1093/carcin/bgu043 PMID: 24510239
16. Qian Z, Zhu G, Tang L, Wang M, Zhang L, Fu j, et al. Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets. Genes Chromosomes Cancer. 2014; 53: 883-894. doi: 10.1002/gcc.22196 PMID: 24935174
17. Yu Z, Zhang C, Chai R, Du Y, Gao X, Xing J, et al. Prognostic significance and molecular mechanism of ATP-binding cassette subfamily C member 4 in resistance to neoadjuvant radiotherapy of locally advanced rectal carcinoma. PLOS ONE. 2014; 9: e85446. doi: 10.1371/journal.pone.0085446 PMID: 24454870
18. Zhao X, Guo Y, Yue W, Zhang L, Gu M, Wang Y. ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer. Onco Targets Ther. 2014; 7: 343-351. doi: 10.2147/OTT.S56029 PMID: 24591841
19. Bagnoli M, Beretta GL, Gatti L, Pilotti S, Alberti P, Tarantino E, et al. Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma. Biomed Res Int. 2013; 2013: 143202. doi: 10.1155/2013/143202 PMID: 24024181
20. Montani M, Hermanns T, Muntener M, Wild P, Sulser T, Kristiansen G. Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression. Virchows Arch. 2013; 462: 437-443. doi: 10.1007/s00428-013-1390-8 PMID: 23503867
21. Norris MD, Smith J, Tanabe K, Tobin P, Flemming C, Scheffer GL, et al. Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. Mol Cancer Ther. 2005; 4: 547-553. PMID: 15827327
22. Huynh T, Norris MD, Haber M, Henderson MJ. ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma. Front Oncol. 2012; 2: 178. doi: 10.3389/fonc.2012.00178 PMID: 23267433
23. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014; 74: 2913-2921. doi: 10.1158/0008-5472.CAN-14-0155 PMID: 24840647
24. Lohr M. Is it possible to survive pancreatic cancer? Nat Clin Pract Gastroenterol Hepatol. 2006; 3: 236-237. PMID: 16672986
25. Zhang Z, Wang J, Shen B, Peng C, Zheng M. The ABCC4 gene is a promising target for pancreatic cancer therapy. Gene. 2012; 491: 194-199. doi: 10.1016/j.gene.2011.09.029 PMID: 21989485
26. Gu X, Manautou JE. Regulation of hepatic ABCC transporters by xenobiotics and in disease states. Drug Metab Rev. 2010; 42: 482-538. doi: 10.3109/03602531003654915 PMID: 20233023
27. Davio CA, Cricco GP, Bergoc RM, Rivera ES. H1 and H2 histamine receptors in N-nitroso-N-methylurea (NMU)-induced carcinomas with atypical coupling to signal transducers. Biochem Pharmacol. 1995; 50: 91-96. PMID: 7605350
28. Hochbaum D, Tanos T, Ribeiro-Neto F, Altschuler D, Coso OA. Activation of JNK by Epac is independent of its activity as a Rap guanine nucleotide exchanger. J Biol Chem. 2003; 278: 33738-33746. PMID: 12783872
29. Rodriguez MR, Diez F, Ventimiglia MS, Morales V, Copsel S, Vatta MS, et al. Atrial natriuretic factor stimulates efflux of cAMP in rat exocrine pancreas via multidrug resistance-associated proteins. Gastroenterology. 2011; 140: 1292-1302. doi: 10.1053/j.gastro.2010.12.053 PMID: 21237168
30. O'Hayre M, Vazquez-Prado J, Kufareva I, Stawiski EW, Handel TM, Seshagiri S, et al. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer. 2013; 13: 412-424. doi: 10.1038/nrc3521 PMID: 23640210
31. Gloerich M, Bos JL. Epac: defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol. 2010; 50: 355-375. doi: 10.1146/annurev.pharmtox.010909.105714 PMID: 20055708
32. Breckler M, Berthouze M, Laurent AC, Crozatier B, Morel E, Lezoualc'h F. Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications. Cell Signal. 2011; 23: 1257-1266. doi: 10.1016/j.cellsig.2011.03.007 PMID: 21402149
33. Broderdorf S, Zang S, Schaletzki Y, Grube M, Kroemer HK, Jedlitschky G. cAMP regulates expression of the cyclic nucleotide transporter MRP4 (ABCC4) through the EPAC pathway. Pharmacogenet Genomics. 2014; 24: 522-526. doi: 10.1097/FPC.0000000000000084 PMID: 25121519
34. Dreuw A, Hermanns HM, Heise R, Joussen S, Rodriguez F, Marquardt Y, et al. Interleukin-6-type cytokines upregulate expression of multidrug resistance-associated proteins in NHEK and dermal fibroblasts. J Invest Dermatol. 2005; 124: 28-37. PMID: 15654950
35. Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 2002; 12: 258-266. PMID: 12074885
36. Burgun C, Esteve L, Humblot N, Aunis D, Zwiller J. Cyclic AMP-elevating agents induce the expression of MAP kinase phosphatase-1 in PC12 cells. FEBS Lett. 2000; 484: 189-193. PMID: 11078876
37. Hofer AM, Lefkimmiatis K. Extracellular calcium and cAMP: second messengers as "third messengers"? Physiology (Bethesda). 2007; 22: 320-327. PMID: 17928545
38. Osycka-Salut C, Diez F, Burdet J, Gervasi MG, Franchi A, Bianciotti LG, et al. Cyclic AMP efflux, via MRPs and A1 adenosine receptors, is critical for bovine sperm capacitation. Mol Hum Reprod. 2014; 20: 89-99. doi: 10.1093/molehr/gat053 PMID: 23907162